| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00234-010-0776-4 |
| P698 | PubMed publication ID | 20959972 |
| P50 | author | Jean-Philippe Cottier | Q57079482 |
| Laurent Barantin | Q60696150 | ||
| P2093 | author name string | Philippe Bertrand | |
| Pierre Castelnau | |||
| Dominique Sirinelli | |||
| Charlotte Barbier | |||
| Camille Chabernaud | |||
| Catherine Sembely | |||
| P2860 | cites work | Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference | Q70384871 |
| Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain | Q72246113 | ||
| Neurofibromatosis type 1. Part I. Clinical and central nervous system manifestations | Q73919962 | ||
| T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning | Q24297141 | ||
| Molecular genetics of neurofibromatosis type 1 (NF1) | Q24518449 | ||
| Nuclear magnetic resonance spectroscopy and imaging in animal research | Q28201924 | ||
| Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants | Q28591548 | ||
| Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice. | Q30497049 | ||
| Lesions of skin and brain: modern imaging of the neurocutaneous syndromes | Q30990098 | ||
| Intra-cranial manifestations of the neurocutaneous syndromes | Q31484139 | ||
| 1H MR spectroscopy evidence for the varied nature of asymptomatic focal brain lesions in neurofibromatosis type 1. | Q32051059 | ||
| Neuropsychology of infarctions in the thalamus: a review | Q33846284 | ||
| Neurofibromin regulation of ERK signaling modulates GABA release and learning | Q34872465 | ||
| Neurofibromatosis type 1 revisited | Q37360771 | ||
| Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation | Q37383632 | ||
| Brain structure and function in neurofibromatosis type 1: current concepts and future directions. | Q37698830 | ||
| Genetic and Epigenetic Mechanisms in the Pathogenesis of Neurofibromatosis Type 1 | Q40434980 | ||
| Neurofibromatosis type 1 in children: MR imaging and follow-up studies of central nervous system findings. | Q42452707 | ||
| Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities | Q42493921 | ||
| Age-related findings on MRI in neurofibromatosis type 1. | Q42499848 | ||
| Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis | Q42518447 | ||
| Evolution of white matter lesions in neurofibromatosis type 1: MR findings | Q43778620 | ||
| Proton magnetic resonance spectroscopy of brain lesions in children with neurofibromatosis type 1. | Q43801068 | ||
| Proton MR spectroscopy features of normal appearing white matter in neurofibromatosis type 1. | Q44698500 | ||
| Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. | Q46202146 | ||
| Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. | Q46433079 | ||
| Three-dimensional multivoxel proton MR spectroscopy of the brain in children with neurofibromatosis type 1. | Q48121198 | ||
| Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities | Q48125762 | ||
| Spontaneous regression of a tectal mass in neurofibromatosis 1. | Q48426681 | ||
| Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. | Q49114886 | ||
| T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function | Q49136405 | ||
| Visual-spatial performance deficits in children with neurofibromatosis type-1. | Q52103371 | ||
| Thalamic involvement in neurofibromatosis type 1: evaluation with proton magnetic resonance spectroscopic imaging. | Q52169260 | ||
| Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. | Q52211187 | ||
| Short TE proton MRS and neurofibromatosis type 1 intracranial lesions. | Q55476380 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 141-148 | |
| P577 | publication date | 2010-10-20 | |
| P1433 | published in | Neuroradiology | Q15765131 |
| P1476 | title | Proton MR spectroscopic imaging of basal ganglia and thalamus in neurofibromatosis type 1: correlation with T2 hyperintensities | |
| P478 | volume | 53 |
| Q93013961 | Can the Cognitive Phenotype in Neurofibromatosis Type 1 (NF1) Be Explained by Neuroimaging? A Review |
| Q42442141 | Evaluation of the basal ganglia in neurofibromatosis type 1. |
| Q37280185 | GABA deficiency in NF1: A multimodal [11C]-flumazenil and spectroscopy study |
| Q42512482 | Multivariate pattern analysis reveals subtle brain anomalies relevant to the cognitive phenotype in neurofibromatosis type 1. |
Search more.